1 post from day 06/12/2013

Transparency tools in gene patenting for informing policy and practice

Nature Biotechnology,  December 06, 2013 In the recent decision Association for Molecular Pathology v. Myriad Genetics1, the US Supreme Court held that naturally occurring sequences from human genomic DNA are not patentable subject matter. Only certain complementary DNAs (cDNA), modified sequences and methods to use sequences are potenti...

Continue Reading